Navigating Our Way Around Cannabis Stocks: Should We Buy Now?

Cannabis stocks continue to roar on, as the cannabis industry continues to move forward and make good on its promise of high growth.

But returns and profits are a different story, and we are still waiting to see which companies will be the ultimate winners.

Let’s take a look at three of the biggest cannabis companies, some latest developments, and stock price performance.

Aurora Cannabis’s (TSX:ACB)(NYSE:ACB) stock price has rallied 71% year to date and is down 20% from its October 2018 highs in what continues to be a volatile but successful run.

One of the biggest concerns with this stock is the shareholder dilution that has taken place.

Aurora Cannabis shares outstanding have more than doubled in the last year, effectively eating away at existing shareholders’ holdings, and it doesn’t look like this will stop any time soon.

On top of this, the company recently filed a prospectus to enable it to raise up to $750 million through common shares, debt securities, subscription receipts, units, warrants, or any combination thereof during the 25-month period that the prospectus is effective.

This — combined with the mounting losses, as selling, general, and administrative expenses rise and research and development costs rise, as well as increased capital investment into Aurora’s growth plans — makes me nervous about Aurora Cannabis stock and its future path.

Similarly, Canopy Growth’s (TSX:WEED)(NYSE:CGC) stock price has rallied 68% year to date and is down 11% from its October 2018 highs.

Most recently, Canopy Growth has been rallying off the announcement of its plan to acquire leading U.S. cannabis operator Acreage Holdings. In an attempt to keep its first-mover advantage and extend it to the U.S., Canopy Growth has made this unprecedented move to acquire “at such time as cannabis production and sale becomes federally legal in the United States.”

Canopy remains the leading cannabis stock, with one of the most extensive global presences and operations in 12 countries across five continents.

Lastly, Aphria’s (TSX:APHA)(NYSE:APHA) stock price has rallied 28% year to date and is down 52% from its 2018 highs.

With Aphria’s third-quarter fiscal 2019 earnings results, we saw its stock price get hit hard, plummeting almost 15% on the day of the release.

In what may be a sign that the company and the stock is attempting to hit the reset button, we have seen management take a write-down of its Latin American acquisition in the latest quarter. This was partly to blame for a greater-than-expected net loss, but even without this, the net loss was $0.20 per share, as Aphria is also taking a hit from lower-than-expected revenue and higher-than-expected costs.

Final thoughts

In summary, we know that if and when the market turns more risk averse again, cannabis stocks are especially at risk.

So, if you’re thinking of buying, know this and make sure you maintain a well-diversified portfolio to ensure strong overall performance.

Be prepared for a wild ride, and if you’re up for it, add on weakness and take profits to protect your money while you attempt to profit from this burgeoning business.

You might be missing out on one of the biggest opportunities in Canadian investing history…

Marijuana was legalized across Canada on October 17th, and a little-known Canadian company just unlocked what some experts think could be the key to profiting off the coming marijuana boom.

Besides making key partnerships with Facebook and Amazon, they’ve just made a game-changing deal with the Ontario government.

One grassroots Canadian company has already begun introducing this technology to the market – which is why legendary Canadian investor Iain Butler thinks they have a leg up on Amazon in this once-in-a-generation tech race.

This is the company we think you should strongly consider having in your portfolio if you want to position yourself wisely for the coming marijuana boom.

Learn More About This TSX Stock Now

More reading

Fool contributor Karen Thomas has no position in any of the stocks mentioned.

Source: The Fool
Navigating Our Way Around Cannabis Stocks: Should We Buy Now?
The Fool

The Motley Fool
Contributor for
The Motley Fool is dedicated to helping the world invest — better. Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, mutual funds, and premium investing services.

In all we do, we take a different approach.

We believe – and have proven over decades – that the individual investor can beat the market.

We believe that anyone can do it, even if they don’t have a lot of time or money to devote to investing.

We believe in a long-term outlook, helping people build wealth over time.

We believe that the person best positioned to take care of your financial future is you.

And we work tirelessly on behalf of our hundreds of thousands of members who are enjoying the opportunities that come with having enough money to do the things that matter to them.

While we are headquartered in Alexandria, Va., The Motley Fool advocates for the individual investor around the globe with offices in the UK, Australia, Canada, Singapore, and Germany.

Related posts